Archive for October, 2013

Stryker profits down 71% due to recalls

Stryker Corporation reported 3rd-quarter profits down 71% due to ongoing issues related to its Stryker hip replacement recall. The device manufacturer issued a voluntary recall of its Stryker ABG II and Stryker Rejuvenate hip replacement in July 2012.

Read more about Stryker hip replacement issues…

Liver failure warning added to Zithromax label

The U.S. Food and Drug Administration’s Warnings and Precautions, Contraindications, and Adverse Reactions sections of the labeling for Zithromax were updated in January 2011, to include liver failure. The drug, commonly referred to as “Z-Pak,” has been on the market since 1998.

Read more about Z-Pak side effects…

Teenagers more likely to suffer blood clots when taking Yaz or Yasmin

A large number of reported Yaz and Yasmin birth control blood clot victims are teenagers and otherwise healthy young adults, leading parents and teens to be concerned about birth control risks. Girls as young as 14 can be prescribed Yaz and Yasmin.

Read more about Yaz and Yasmin side effects…

SSRIs linked to GI bleeding

Antidepressants in a class known as selective serotonin reuptake inhibitors (SSRIs) have been found to be the only antidepressants to cause bleeding in the upper gastrointestinal (GI) tract, even with short-term use. The most recent study to confirm those findings has been published in the American Journal of Psychiatry.

Read more about potential SSRI antidepressant side effects…

BioMet Inc. buys company to enter spine market

BioMet Inc. will acquire Lanx Inc. in the attempt to break into the spinal surgery device market. BioMet is one of the primary manufacturers in the surgical device market, and manufactured the controversial BioMet M2a Magnum hip replacement.

Read more about BioMet’s controversial products…

South Korea halts sales of Zithromax for at least 3 months

South Korea’s Ministry of Food and Drug Safety has suspended the sale of Pfizer’s antibiotic Zithromax, commonly known as Z-Pak, for at least three months. The health agency issued the suspension due to inaccurate dosage instructions, which could lead to severe side effects.

Read more about severe Zithromax side effects…

New SSRI antidepressant is similar to Zoloft

A new selective serotonin reuptake inhibitor antidepressant (SSRI) has been approved by the U.S. Food and Drug Administration. The drug, “Brintellix,” has been called a “novel” drug in that it is nearly identical in effect to other SSRI antidepressants, including Zoloft.

Read more about potential SSRI antidepressant side effects…

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101


Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.